Eyestem Research Pvt Ltd.
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.eyestem.com
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)phase_1_2
1 (33.3%)Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
Phase 1
Recruiting
- Conditions
- Geographic AtrophyMacular DegenerationAge-Related Macular DegenerationEye DiseasesRetinal Disease
- Interventions
- Drug: Eyecyte-RPE™
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Eyestem Research Pvt. Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT06394232
- Locations
- 🇮🇳
Shri Ganapati Netralaya, Jalna, Maharashtra, India
🇮🇳All India Institute of Medical Sciences, Delhi, New Delhi, India
🇮🇳L V Prasad Eye Institute, Hyderabad, Telangana, India
News
No news found